Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3)
Clinical trial NCT06519097 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06519097
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-09
- Primary completion
- 2026-09-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.